Table III.

Increases from baseline in haemoglobin levels

		Sotatercept dose group
Haemoglobin increase	Placebo (n = 6)	0·1 mg/kg (n = 8)	0·3 mg/kg (n = 8)	0·5 mg/kg (n = 8)
≥10 g/l on day 29 (after first dose)	2 (33·3)	1 (12·5)	1 (12·5)	5 (62·5)
≥15 g/l on day 29 (after first dose)	0	0	1 (12·5)	3 (37·5)
≥20 g/l on day 29 (after first dose)	0	0	0	2 (25·0)
≥10 g/l at any time and sustained for ≥28 d	4 (66·7)	5 (62·5)	3 (37·5)	7 (87·5)
≥15 g/l at any time and sustained for ≥28 d	2 (33·3)	3 (37·5)	3 (37·5)	5 (62·5)
≥20 g/l at any time and sustained for ≥28 d	0	2 (25·0)	3 (37·5)	2 (25·0)